Acusensus (ACE.AX) Stock Price
Acusensus Price
Over the last 8 years Acusensus grew revenue by 156.5% annually, reaching 86.17 M AUD. For Acusensus, the net margin of -28.2% is down versus 5.0% a few years ago. The consensus 12-month price target for Acusensus is 2.35 AUD, about 128.9% above where the stock trades today. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus.
Acusensus stock price
Acusensus business model & stock analysis
Frequently asked questions about Acusensus
Analysts currently set an average price target of 2.35 AUD for the Acusensus stock (median: 2.35 AUD), implying +128.9 % versus the latest price. The consensus is based on 6 analyst ratings.
6 analysts currently rate the Acusensus stock: 5 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Acusensus share trades at 0.64 EUR (1.02 AUD).
The revenue of Acusensus is 86.17 M AUD. This figure is based on current financial data and reflects the company's business performance.
The profit of Acusensus is -24.29 M AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Acusensus is currently -7.15. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Acusensus stock.
The price-to-sales ratio (P/S) of Acusensus is currently 2.02. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Acusensus stock.
The Eulerpool Quality Score for Acusensus is 2/10.
The ISIN of Acusensus is AU0000259582. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Acusensus is ACE.AX. The ticker symbol is used to trade Acusensus shares on the stock exchange.
Acusensus stock
Acusensus Peer Group
Acusensus FIGI
All fundamentals and in-depth analysis of Acusensus
Our stock analysis for Acusensus stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Acusensus. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.